MedPath

DOCETAXEL INJECTION

DOCETAXEL INJECTION

Discontinued
DIN Number

02412233

Drug Class

Human

Market Date

Mar 28, 2014

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02412233
AIG Number0127884003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CD02 DOCETAXEL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DOCETAXELActive
Strength: 80 MG / 2.88 ML
Monograph: DOCETAXEL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.